February 25, 2015

California-based Finistere Ventures, one of the pioneering capital firms in the agtech space, has announced the first closing of its new Agtech fund, Finistere II in collaboration with Bayer CropScience and AVAC Ltd. The $150 million fund focuses primarily on new agtech solutions that address food production, nutrition, and sustainability that respond to decreasing arable land resources, climate change, and global population demographic shifts. The focus of the fund is on North America but opportunities will also utilize Finistere’s multinational network of partners in global agtech centers, including Australia, New Zealand, Canada, and Israel.

Finistere is also expected to announce a collaborative agreement in Israel this quarter, and announce the development of an Agtech pipeline strategy supported by research organizations in Australia and New Zealand.

On Thursday Global AgInvesting will share its interview with Finistere Ventures cofounder and Partner, Arama Kukutai.

Full press release:

February 25, San Diego – Finistere Ventures, a California-based innovation capital firm and one of the pioneers in the rapidly growing agriculture technology (Agtech) sector, announced the first closing of its new $150M AgtechFund, Finistere II. The Fund focuses on new technology solutions in food productivity, sustainability, and nutrition to address the ever-decreasing agricultural land resources, climate change, and changing population demographics. Finistere is collaborating with Bayer CropScience, AVAC Ltd., and other partners to identify and invest in world-class technologies across early-to-growth stage companies in the Agtech space.

“We are excited by the promising technologies and companies in the Agtech space that need both capital and the strategic, technical, and operating expertise that we bring as partners and investors,” said Finistere Ventures cofounder and Partner, Arama Kukutai. “We are delighted to now have an aligned group of financial investors and strategic partners that includes Bayer CropScience supporting our efforts.”

Finistere, which began investing in Agtech in 2005, has seen a pattern of increasing investor interest including a more diverse set of entrepreneurs and significant opportunities in commercializing the pipeline of science and technology funded by public investment around the globe. “The timing for a new Fund coincides with the new wave of innovation needed to create the next Green Revolution in agriculture,” said Jerry Caulder, a leader in agricultural biotechnology and Chairman of Finistere Ventures. “By partnering with the expanding VC interest, we can build on the positive results we’ve had in this sector”.

By investing in future technologies, Bayer CropScience aims to advance global food security.

“The world faces difficult challenges to its food security with 9 plus billion people to feed by 2050,” said Dr. Adrian Percy, Head of Global Research and Development, Bayer CropScience AG. “The investment with Finistere Ventures complements our vision for collaborating with others in delivering new innovation to growers to enhance yields necessary to provide access to safe and affordable food for this growing population and shifting tastes of consumers. As an innovation led company, we believe fresh approaches and technologies for our farmer community will be critical to meeting these challenges of tomorrow and look forward to seeing this effort come to fruition.”

While the Fund is primarily focused on North American opportunities, the Finistere II Fund will invest in companies from ‘global centers of excellence’ in Agtech. A key feature of the firm is Finistere’s international network of partners that include Australia, New Zealand, Canada and Israel, all recognized for their significant pipelines of Agtech related R&D, and as major agricultural producers in their own right.

“We are partnering with Finistere to not only grow financial returns but to help leverage the major R&D investments being made in Canadian universities and institutions that need connections to the talent and ecosystems in the U.S. to flourish,” said Dr. Michael Raymont, Chief Executive Officer of the Calgary-based investment firm AVAC Ltd. Canada has a proven track record of pioneering new technologies in crop and food – Canola, for example, has grown to a crop that is planted in over 25 million acres in Canada alone.

Finistere is also expected to announce collaboration agreements this quarter in Israel, and is developing an Agtech pipeline strategy with support from research organizations in Australia and New Zealand.

Finistere will be operating from their established San Diego, Calif. office and a new office in Palo Alto, CA headed by its new partner Dr. Spencer Maughan, formerly a Vice President at Venrock. According to Maughan, “Silicon Valley has become a major hub for new Agtech companies, and a more diverse group of investors. With California as the leading agricultural state by value and the biggest concentration of venture investing in the world, the prospects for investment in Agtech are ideal.”

About Finistere Ventures

Finistere Ventures, a leading California-based agricultural technology and life sciences venture capital investor, and their team has developed and invested in some of the most successful Ag Tech companies of the last 20 years. Founded in 2005, the company partners with other entrepreneurs and creative thinkers to build innovative companies that have the potential to transform modern agriculture, increase food security, improve nutrition and enhance sustainability. Their applied experience as operators, and pioneering role in Ag Tech, is actively utilized to benefit its portfolio companies and Partners. Finistere has global access to the best new technologies from centers of Ag Tech excellence in the U.S., Australia, Israel, New Zealand and Canada through its venture partner networks. Finistere’s locations in San Diego and Palo Alto, California keeps them connected to the centers of mainstream venture investment and the world’s leading innovation ecosystem. Visit FinistereFund2.com.

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,819 million (2013) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 22,400 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

About AVAC Ltd.

AVAC Ltd is an investment company with over 16 years of experience in financing early-stage innovative business opportunities and providing both capital and other value-added services to grow commercial business successes. AVAC invests in promising ventures in value-added agri-business, information and communications technologies, life sciences, and other industrial technology sectors. AVAC also manages an active early-stage venture capital fund-of-funds investment pool and the Accelerate Fund, an angel co-investment fund. Find out more: www.avacltd.com & www.acceleratefund.ca

Contact:

Lauren Lehman

L3 Healthcare

LLehman@L3Healthcare.com

858-437-1107